Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales (2019 - 2025)

Historic Return on Sales for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.09%.

  • Eton Pharmaceuticals' Return on Sales fell 1500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.1% for FY2024, which is 700.0% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Return on Sales stood at 0.09% for Q3 2025, which was down 1500.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Return on Sales ranged from a high of 0.43% in Q1 2021 and a low of 7.86% during Q3 2021
  • For the 5-year period, Eton Pharmaceuticals' Return on Sales averaged around 0.7%, with its median value being 0.1% (2024).
  • The largest annual percentage gain for Eton Pharmaceuticals' Return on Sales in the last 5 years was 2358400bps (2021), contrasted with its biggest fall of -25621600bps (2021).
  • Over the past 5 years, Eton Pharmaceuticals' Return on Sales (Quarter) stood at 0.17% in 2021, then crashed by -37bps to 0.11% in 2022, then tumbled by -171bps to 0.08% in 2023, then soared by 32bps to 0.05% in 2024, then plummeted by -67bps to 0.09% in 2025.
  • Its Return on Sales stands at 0.09% for Q3 2025, versus 0.14% for Q2 2025 and 0.88% for Q1 2025.